American Academy of Pain Medicine (AAPM)

Stevens R, Simons G, Brand T, Hettema W, Corradini L, Pollenter S. Phase 1 study of the safety and tolerability of single ascending doses of the novel oral CCR2 antagonist CNTX-6970 in healthy volunteers [abstract]. Pain Med. 2018;19(4).
Published by Oxford University Press on behalf of the American Academy of Pain Medicine. Please visit: